BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28123191)

  • 21. Thromboprophylaxis adherence to the ninth edition of American college of chest physicians antithrombotic guidelines in a tertiary care centre: a cross-sectional study.
    Thériault T; Touchette M; Goupil V; Echenberg D; Lanthier L
    J Eval Clin Pract; 2016 Dec; 22(6):952-957. PubMed ID: 27265818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
    Thaler J; Ay C; Pabinger I
    Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing different venous thromboembolism risk assessment machine learning models in Chinese patients.
    Wang X; Yang YQ; Liu SH; Hong XY; Sun XF; Shi JH
    J Eval Clin Pract; 2020 Feb; 26(1):26-34. PubMed ID: 31840330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are venous thromboembolism risk assessment tools reliable in the stratification of microvascular risk following lower extremity reconstruction?
    Geoghegan L; Super J; Machin M; Gimzewska M; Onida S; Hettiaratchy S; Davies AH
    JPRAS Open; 2021 Sep; 29():45-54. PubMed ID: 34095427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The additional benefit of graduated compression stockings to pharmacologic thromboprophylaxis in the prevention of venous thromboembolism in surgical inpatients.
    Mandavia R; Shalhoub J; Head K; Davies AH
    J Vasc Surg Venous Lymphat Disord; 2015 Oct; 3(4):447-455.e1. PubMed ID: 26992625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective, controlled trial of a pharmacy-driven alert system to increase thromboprophylaxis rates in medical inpatients.
    Garcia DA; Highfill J; Finnerty K; Varoz E; McConkey S; Hutchinson K; Libby E
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):541-5. PubMed ID: 19584716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in Internal Medicine. Findings from a multicenter, prospective study.
    Gussoni G; Campanini M; Silingardi M; Scannapieco G; Mazzone A; Magni G; Valerio A; Iori I; Ageno W;
    Thromb Haemost; 2009 May; 101(5):893-901. PubMed ID: 19404543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
    Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
    Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Padua prediction score or clinical judgment for decision making on antithrombotic prophylaxis: a quasi-randomized controlled trial.
    Germini F; Agnelli G; Fedele M; Galli MG; Giustozzi M; Marcucci M; Paganelli G; Pinotti E; Becattini C
    J Thromb Thrombolysis; 2016 Oct; 42(3):336-9. PubMed ID: 27052516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Underutilization of pharmacological thromboprophylaxis in obstetrics and gynaecology patients in the absence of a risk assessment tool.
    Zaher GF
    J Taibah Univ Med Sci; 2018 Feb; 13(1):10-15. PubMed ID: 31435297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary thromboprophylaxis in hospices: the association between risk of venous thromboembolism and development of symptoms.
    Johnson MJ; McMillan B; Fairhurst C; Gabe R; Ward J; Wiseman J; Pollington B; Noble SI
    J Pain Symptom Manage; 2014 Jul; 48(1):56-64. PubMed ID: 24331547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of thromboprophylaxis in hospitalised medical patients. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE).
    Spirk D; Nendaz M; Aujesky D; Hayoz D; Beer JH; Husmann M; Frauchiger B; Korte W; Wuillemin WA; Righini M; Bounameaux H; Kucher N
    Thromb Haemost; 2015 May; 113(5):1127-34. PubMed ID: 25608607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
    Raskob GE; Spyropoulos AC; Zrubek J; Ageno W; Albers G; Elliott CG; Halperin J; Haskell L; Hiatt WR; Maynard GA; Peters G; Spiro T; Steg PG; Suh EY; Weitz JI
    Thromb Haemost; 2016 Jun; 115(6):1240-8. PubMed ID: 26842902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of the External Validity of Randomized Controlled Trials Supporting Clinical Care Guidelines: The Case of Thromboprophylaxis.
    Morin-Ben Abdallah S; Dutilleul A; Nadon V; Yang JW; Marchand-Sénécal X; Van Nguyen P; Lamarre-Cliche M; Wistaff R; Kolan C; Laskine M; Durand M
    Am J Med; 2016 Jul; 129(7):740-5. PubMed ID: 26968472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease.
    Dwyer JP; Javed A; Hair CS; Moore GT
    Intern Med J; 2014 Aug; 44(8):779-84. PubMed ID: 24893756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scoring Systems for Estimating Risk of Venous Thromboembolism in Hospitalized Medical Patients.
    Barbar S; Prandoni P
    Semin Thromb Hemost; 2017 Jul; 43(5):460-468. PubMed ID: 28166598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thromboprophylaxis in medically ill patients at risk for venous thromboembolism.
    Burleigh E; Wang C; Foster D; Heller S; Dunn D; Safavi K; Griffin B; Smith J
    Am J Health Syst Pharm; 2006 Oct; 63(20 Suppl 6):S23-9. PubMed ID: 17032931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between Caprini and Padua risk assessment models for hospitalized medical patients at risk for venous thromboembolism: a retrospective study.
    Liu X; Liu C; Chen X; Wu W; Lu G
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):538-43. PubMed ID: 27297558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the ENDORSE study results on thromboprophylaxis prescribing patterns in medical patients attending the emergency department.
    de Lorenzo-Pinto A; García-Sánchez R; Pascual Izquierdo C; Durán-García ME; Castuera-Gil AI; Andueza-Lillo JA; Sanjurjo-Sáez M
    Int J Clin Pract; 2015 Jan; 69(1):81-6. PubMed ID: 24852483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.